Johanna Kauschinger - Klinikum Rechts Isar, Tech Univ Munich

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 5 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Selective Inhibition of BCL-2 is a Promising Target in Patients with High-Risk Myelodysplastic Syndromes and Adverse Mutational Profile

Veronika Reidel,Johanna Kauschinger,Richard T Hauch,Catharina Müller-Thomas,Niroshan Nadarajah,Rainer Burgkart,Burkhard Schmidt,Dirk Hempel,Anne Jacob,Julia Slotta-Huspenina,Ulrike Höckendorf,Christian Peschel,Wolfgang Kern, Torsten Haferlach,Katharina S Götze,Stefanie Jilg,Philipp J Jost

Oncotarget（2018）

Cited18Views0WOSBibtex

Combination of 5-Azacytidine and ABT-199 Has a Synergistic Apoptotic Effect in High-Risk MDS/sAML after HMA Failure

Stefanie Jilg,Johanna Kauschinger, Veronika Reidel,Catharina Muller-Thomas,Richard Hauch,Johannes Schauwecker,Burkhard Schmidt,Ulrike Hockendorf,Christian Peschel,Katharina Gotze,Philipp J. Jost

Blood（2016）

Cited5Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn